Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Depreciation & Amortization (CF) (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 15.51% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.4 million, a 21.96% decrease, with the full-year FY2025 number at $5.4 million, down 21.96% from a year prior.
  • Depreciation & Amortization (CF) was $1.3 million for Q4 2025 at Anika Therapeutics, down from $1.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.9 million in Q3 2024 to a low of $1.3 million in Q2 2025.
  • A 5-year average of $1.6 million and a median of $1.6 million in 2023 define the central range for Depreciation & Amortization (CF).
  • Biggest YoY gain for Depreciation & Amortization (CF) was 184.43% in 2021; the steepest drop was 58.33% in 2021.
  • Anika Therapeutics' Depreciation & Amortization (CF) stood at $1.8 million in 2021, then dropped by 3.26% to $1.7 million in 2022, then fell by 5.35% to $1.6 million in 2023, then fell by 4.18% to $1.6 million in 2024, then dropped by 15.51% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Depreciation & Amortization (CF) are $1.3 million (Q4 2025), $1.4 million (Q3 2025), and $1.3 million (Q2 2025).